dsfgdsfg
This week the FDA approved Addyi/Flibanserin, the first drug to treat premenopausal women with Hypoactive Sexual Desire Disorder (HSDD).
“Woohoo! Finally!” you may be thinking. Before you go rushing off to “ask your doctor if Flibanserin/ Addyi” is right for you, there are some things you should know.